BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17013515)

  • 1. Liver cirrhosis and hepatic stellate cells.
    Brandão DF; Ramalho LN; Ramalho FS; Zucoloto S; Martinelli Ade L; Silva Ode C
    Acta Cir Bras; 2006; 21 Suppl 1():54-7. PubMed ID: 17013515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells.
    Geremias AT; Carvalho MA; Borojevic R; Monteiro AN
    BMC Gastroenterol; 2004 Dec; 4():30. PubMed ID: 15579200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
    Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular sources of extracellular matrix in hepatic fibrosis.
    Wells RG
    Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions.
    Ezhilarasan D; Najimi M
    J Cell Physiol; 2023 Jan; 238(1):70-81. PubMed ID: 36409708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrotic treatments for chronic liver diseases: The present and the future.
    Odagiri N; Matsubara T; Sato-Matsubara M; Fujii H; Enomoto M; Kawada N
    Clin Mol Hepatol; 2021 Jul; 27(3):413-424. PubMed ID: 33317250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis.
    Ozaki S; Sato Y; Yasoshima M; Harada K; Nakanuma Y
    Liver Int; 2005 Aug; 25(4):817-28. PubMed ID: 15998433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
    Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
    J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis].
    Casu A; Canepa M; Nanni G
    Pathologica; 1994 Oct; 86(5):467-99. PubMed ID: 7739873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of hepatic fibrosis and the role of cytokines.
    Lissoos TW; Davis BH
    J Clin Gastroenterol; 1992 Jul; 15(1):63-7. PubMed ID: 1500664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
    Ezhilarasan D; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
    Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
    Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
    Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
    Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.